Keilah Garcia Netto
UNSW, NSW, Australia
Presentations this author is a contributor to:
Novel drug (CRO-67) in commercial pipeline have both anti-tumour and stromal reprogramming capacity (#108)
1:00 PM
Shannon Chiang
Lunch & Poster Viewing (Even Numbers)
βIII-Tubulin knockdown sensitises pancreatic tumours to the tumour-specific death ligand TRAIL. (#37)
12:25 PM
George Sharbeen
Concurrent Session - Cancer Biology